(Q35601639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Tailoring adjuvant treatments for the individual breast cancer patient (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

R D Gelber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

M Castiglione-Gertsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

A S Coates

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

A Goldhirsch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

International Breast Cancer Study Group (IBCSG)

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

558-568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Overhauling the breast cancer overview: are subsets subversive?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Subsets within the chemotherapy overview. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900166-8

7 January 2021

10.1016/S0960-9776(03)00166-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14659135%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference